ANALYSIS OF THE INFLUENCE OF DNMT3A ON MEASURABLE RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA WITH MUTATION OF NPM1
Por:
Onate, G, Bataller, A, Garrido, A, Esteve, J, Arnan, M, Vives, S, Coll, R, Bargay, J, Salamero, O, Escoda, L, Garcia, A, de Llano, MPQ, Aljarilla, A, Brunet, S, Nomdedeu, JF, Sierra, J and Pratcorona, M
Publicada:
21 oct 2019
Categoría:
Hematology
Resumen:
Filiaciones:
Onate, G:
Hosp Santa Creu & Sant Pau, Barcelona, Spain
Bataller, A:
Hosp Clin Barcelona, Barcelona, Spain
Garrido, A:
Hosp Santa Creu & Sant Pau, Barcelona, Spain
Esteve, J:
Hosp Clin Barcelona, Barcelona, Spain
Arnan, M:
Hosp Duran & Reynals, ICO Hospitalet, Barcelona, Spain
:
Hosp Badalona Germans Trias & Pujol, Badalona, Spain
Coll, R:
Hosp Josep Trueta, Inst Catala Oncol, Girona, Spain
Bargay, J:
Hosp Son Llatzer, Palma De Mallorca, Spain
Salamero, O:
Hosp Valle De Hebron, Barcelona, Spain
Escoda, L:
Hosp Joan 23, Tarragona, Spain
Garcia, A:
Hosp Arnau Vilanova, Lleida, Spain
de Llano, MPQ:
Hosp Virgen Victoria, Malaga, Spain
Aljarilla, A:
Hosp Santa Creu & Sant Pau, Barcelona, Spain
Brunet, S:
Hosp Santa Creu & Sant Pau, Barcelona, Spain
Nomdedeu, JF:
Hosp Santa Creu & Sant Pau, Barcelona, Spain
Sierra, J:
Hosp Santa Creu & Sant Pau, Barcelona, Spain
Pratcorona, M:
Hosp Santa Creu & Sant Pau, Barcelona, Spain
|